Market Cap ₹42 Cr.
Stock P/E 0.0
P/B 0.7
Current Price ₹40.1
Book Value ₹ 58.9
Face Value 10
52W High ₹61.7
Dividend Yield 0%
52W Low ₹ 36.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Net Sales | 35 | 34 | 33 | 33 | 24 | |
Other Income | 0 | 0 | 0 | 0 | 0 | |
Total Income | 35 | 34 | 33 | 33 | 24 | |
Total Expenditure | 28 | 30 | 27 | 25 | 19 | |
Operating Profit | 7 | 4 | 5 | 8 | 4 | |
Interest | 2 | 2 | 2 | 2 | 0 | |
Depreciation | 2 | 2 | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 3 | -1 | 2 | 6 | 3 | |
Provision for Tax | 1 | -0 | -0 | 2 | 1 | |
Profit After Tax | 1 | -1 | 2 | 4 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | -1 | 2 | 4 | 2 | |
Adjusted Earnings Per Share | 0 | 0 | 2.9 | 5.1 | 1.7 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -27% | -11% | 0% | 0% |
Operating Profit CAGR | -50% | 0% | 0% | 0% |
PAT CAGR | -50% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -11% | NA% | NA% | NA% |
ROE Average | 5% | 18% | 11% | 11% |
ROCE Average | 7% | 17% | 13% | 13% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Shareholder's Funds | 12 | 11 | 14 | 17 | 64 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 18 | 17 | 13 | 3 | 4 |
Other Non-Current Liabilities | -3 | -3 | -3 | -2 | -2 |
Total Current Liabilities | 13 | 13 | 10 | 14 | 8 |
Total Liabilities | 40 | 39 | 33 | 31 | 74 |
Fixed Assets | 20 | 19 | 17 | 17 | 17 |
Other Non-Current Assets | 5 | 4 | 0 | 0 | 21 |
Total Current Assets | 15 | 16 | 12 | 11 | 34 |
Total Assets | 40 | 39 | 33 | 31 | 74 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 1 | 0 | 0 |
Cash Flow from Operating Activities | 5 | 4 | 7 | 9 | -40 |
Cash Flow from Investing Activities | -0 | -0 | 0 | 0 | -2 |
Cash Flow from Financing Activities | -5 | -3 | -7 | -10 | 46 |
Net Cash Inflow / Outflow | 0 | 1 | -0 | -0 | 3 |
Closing Cash & Cash Equivalent | 0 | 1 | 0 | 0 | 4 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 0 | 2.92 | 5.11 | 1.74 |
CEPS(Rs) | 5.03 | 1.8 | 4.79 | 6.74 | 2.85 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0 | 0 | 14.46 | 19.98 | 58.94 |
Core EBITDA Margin(%) | 19.53 | 10.1 | 16.62 | 25.09 | 17.31 |
EBIT Margin(%) | 13.84 | 4.1 | 12.82 | 22.3 | 13.36 |
Pre Tax Margin(%) | 7.78 | -3.17 | 5.37 | 17.4 | 11.52 |
PAT Margin (%) | 3.95 | -2.57 | 6.26 | 10.89 | 7.78 |
Cash Profit Margin (%) | 10.18 | 3.77 | 10.25 | 14.38 | 12.74 |
ROA(%) | 3.4 | -2.19 | 5.72 | 11.1 | 3.47 |
ROE(%) | 11.05 | -7.23 | 18.94 | 29.65 | 4.82 |
ROCE(%) | 12.09 | 3.69 | 13.49 | 29.36 | 6.69 |
Receivable days | 91.86 | 81.4 | 78.74 | 93.14 | 144.47 |
Inventory Days | 21.33 | 22.92 | 16.78 | 9.43 | 13.19 |
Payable days | 230.64 | 294.78 | 184.77 | 381.81 | 235.49 |
PER(x) | 0 | 0 | 0 | 0 | 25.73 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0.76 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.98 | 0.87 | 0.72 | 0.47 | 2.24 |
EV/Core EBITDA(x) | 4.86 | 8.35 | 4.29 | 1.83 | 12.24 |
Net Sales Growth(%) | 0 | -2.88 | -2.51 | 0.34 | -28.38 |
EBIT Growth(%) | 0 | -71.25 | 205.02 | 74.56 | -57.1 |
PAT Growth(%) | 0 | -163.19 | 337.36 | 74.59 | -48.87 |
EPS Growth(%) | 0 | 0 | 337.36 | 74.59 | -65.91 |
Debt/Equity(x) | 2.2 | 2.05 | 1.68 | 0.62 | 0.15 |
Current Ratio(x) | 1.17 | 1.18 | 1.14 | 0.82 | 4.28 |
Quick Ratio(x) | 1.02 | 1.02 | 1.06 | 0.76 | 4.17 |
Interest Cover(x) | 2.28 | 0.56 | 1.72 | 4.55 | 7.27 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.2 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
Promoter | 54.29 | 54.29 | 54.29 | 54.29 | 54.29 | 54.29 | 54.29 | 54.29 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 45.71 | 45.71 | 45.71 | 45.71 | 45.71 | 45.71 | 45.71 | 45.71 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
Promoter | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About